Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01291 |
| Species: | Homo sapiens |
| Position : | chr20:46120155-46120433 |
| Year: | 2015 |
| Title: | Correlation of the Osteoarthritis Susceptibility Variants That Map to Chromosome 20q13 With an Expression Quantitative Trait Locus Operating on NCOA3 and With Functional Variation at the Polymorphism rs116855380 |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chondrosarcoma |
| PMID: | 26211391 |
| MONDO: | MONDO:0005172 |
| Tissue: | Articular cartilage |
| Tissue Ontology ID: | UBERON:0002418 |
| Cell Source: | SW1353 |
| CVCL ID: | CVCL_0543 |
| Cell Type: | chondrosarcoma cell |
| Cell Ontology ID: | CL:0000138 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay, EMSA, RT-RT-qPCR, Western blot, siRNA-mediated gene knockdown |
| Target gene : | NCOA3 |
| TF name : |
| Regulatory State : | Silenced |
| GeneName | Pathway Name | Source | Gene Number |
|---|